⌘K

Login Start Free

Home/Filings/4/0000882796-05-000032

4//SEC Filing

BIOCRYST PHARMACEUTICALS INC 4

Accession 0000882796-05-000032

$BCRXCIK 0000882796operating

View on SEC.gov Company Profile

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 5:17 PM ET

Size

18.0 KB

Accession

0000882796-05-000032

Insider Transaction Report

Form 4

Period: 2005-07-15

BIOCRYST PHARMACEUTICALS INCBCRX

BENNETT J CLAUDE

DirectorPresident

Transactions

Exercise/Conversion
Stock Option
2005-07-13$1.04/sh−623$648→ 434,173 total
Exercise: $1.04From: 2003-12-11Exp: 2012-12-10→ Common Stock (623 underlying)
Exercise/Conversion
Common Stock
2005-07-13$3.59/sh+3,800$13,642→ 23,269 total
Exercise/Conversion
Common Stock
2005-07-13$1.04/sh+623$648→ 25,788 total
Exercise/Conversion
Stock Option
2005-07-13$3.59/sh−3,800$13,642→ 437,846 total
Exercise: $3.59From: 2002-12-12Exp: 2011-12-11→ Common Stock (3,800 underlying)
Exercise/Conversion
Common Stock
2005-07-13$1.18/sh+1,896$2,237→ 25,165 total
Exercise/Conversion
Common Stock
2005-07-13$0.87/sh+3,050$2,654→ 28,838 total
Exercise/Conversion
Stock Option
2005-07-13$0.87/sh−3,050$2,654→ 434,796 total
Exercise: $0.87From: 2003-02-03Exp: 2013-02-03→ Common Stock (3,050 underlying)
Exercise/Conversion
Stock Option
2005-07-13$1.18/sh−1,896$2,237→ 432,277 total
Exercise: $1.18From: 2003-08-05Exp: 2012-08-04→ Common Stock (1,896 underlying)

Footnotes (1)

[F1]Exercise and hold only

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000882796

Filing Metadata

Form type: 4
Filed: Jul 12, 8:00 PM ET
Accepted: Jul 13, 5:17 PM ET
Size: 18.0 KB

View on SEC.gov